Morgan Stanley (NYSE:MS) analyst Dara Mohsenian maintained a Sell rating on Clorox (NYSE:CLX) on Wednesday, setting a price target of $154, which is approximately 5.50% below the present share price of $162.96.
Mohsenian expects Clorox to post earnings per share (EPS) of $0.79 for the fourth quarter of 2021.
The current consensus among 11 TipRanks analysts is for a Moderate Sell rating of shares in Clorox, with an average price target of $158.2.
The analysts price targets range from a high of $194 to a low of $143.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $1.8 billion and a net profit of $108 million. The company's market cap is $20.02 billion.
According to TipRanks.com, Morgan Stanley analyst Dara Mohsenian is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 6.0% and a 64.44% success rate.
Founded in 1913, California-based The Clorox Co . manufactures and markets consumer and professional products. It operates through four business segments: Health and Wellness, Household, Lifestyle, and International.